SCHEMBL20152162

SCHEMBL20152162

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c5c6ccccc6n(-c6nc7ccccc7nc6-c6ccccc6)c5ccc43)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.38
CASP1 P29466 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
KDM4E B2RXH2 6/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ACHE P22303 1/20 0.37
ALDH1A1 P00352 5/20 0.36
HPGD P15428 3/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PDE10A Q9Y233 2/20 0.35
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MEN1 O00255 2/20 0.34
POLB P06746 2/20 0.34
KMT2A Q03164 2/20 0.34
TERT O14746 1/20 0.34
SLC2A1 P11166 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19655101 0.89 HSD17B10 (0.46) HSD17B10CASP1HRH4KDM4EL3MBTL1
SCHEMBL20152186 0.88 ALDH1A1 (0.48) HSD17B10CASP1HRH4KDM4EL3MBTL1
SCHEMBL20152204 0.88 MEN1 (0.41) HSD17B10CASP1HRH4KDM4EL3MBTL1
SCHEMBL20152208 0.87 KDM4E (0.38) KDM4EL3MBTL1ACHEALDH1A1HPGD
SCHEMBL20152179 0.86 KDM4E (0.49) HSD17B10CASP1KDM4EL3MBTL1ACHE
SCHEMBL20152135 0.86 HSD17B10 (0.43) HSD17B10CASP1HRH4KDM4EL3MBTL1
SCHEMBL12175712 0.86 MEN1 (0.42) KDM4EL3MBTL1ACHEALDH1A1HPGD
SCHEMBL19640843 0.84 KDM4E (0.45) HSD17B10CASP1HRH4KDM4EL3MBTL1
SCHEMBL19655112 0.83 HSD17B10 (0.38) HSD17B10CASP1HRH4KDM4EL3MBTL1
SCHEMBL19653881 0.82 HSD17B10 (0.39) HSD17B10CASP1HRH4KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662196-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-05-26 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662196-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 HSD17B10 1221/4885CASP1 2079/4885HRH4 1993/4885
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 HSD17B10 1221/4885CASP1 2079/4885HRH4 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.